Parechovirus A Circulation and Testing Capacities in Europe, 2015-2021

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2024 Jan 25

PMID 38270192

Authors

Laura Bubba

Eeva K Broberg

Thea K Fischer

Peter Simmonds

Heli Harvala

Affiliations

Soon will be listed here.

Abstract

Parechovirus infections usually affect neonates and young children; manifestations vary from asymptomatic to life-threatening. We describe laboratory capacity in Europe for assessing parechovirus circulation, seasonality, and epidemiology. We used retrospective anonymized data collected from parechovirus infection case-patients identified in Europe during January 2015-December 2021. Of 21 laboratories from 18 countries that participated in the study, 16 (76%) laboratories with parechovirus detection capacity reported 1,845 positive samples; 12/16 (75%) with typing capability successfully identified 517 samples. Parechovirus A3 was the most common type (n = 278), followed by A1 (153), A6 (50), A4 (13), A5 (22), and A14 (1). Clinical data from 1,269 participants highlighted correlation of types A3, A4, and A5 with severe disease in neonates. We observed a wide capacity in Europe to detect, type, and analyze parechovirus data. To enhance surveillance and response for PeV outbreaks, sharing typing protocols and data on parechovirus-positive cases should be encouraged.

Citing Articles

Understanding neurotropic enteric viruses: routes of infection and mechanisms of attenuation.

Lulla V, Sridhar A Cell Mol Life Sci. 2024; 81(1):413.

PMID: 39365457 PMC: 11452578. DOI: 10.1007/s00018-024-05450-6.

Protective role of antibodies in enteric virus infections: Lessons from primary and secondary immune deficiencies.

Riller Q, Schmutz M, Fourgeaud J, Fischer A, Neven B Immunol Rev. 2024; 328(1):243-264.

PMID: 39340232 PMC: 11659928. DOI: 10.1111/imr.13402.

First whole genome sequencing and analysis of human parechovirus type 3 causing a healthcare-associated outbreak among neonates in Hungary.

Deezsi-Magyar N, Novak N, Lukacs A, Tarcsai K, Hajdu A, Takacs L Eur J Clin Microbiol Infect Dis. 2024; 43(12):2341-2350.

PMID: 39331310 PMC: 11608160. DOI: 10.1007/s10096-024-04950-4.

Prevalence and genetic diversity of Parechovirus.

Zheng J, Zhou Z, Liao Z, Qiu Y, Ge X, Huang X Virus Res. 2024; 349:199461.

PMID: 39278352 PMC: 11422565. DOI: 10.1016/j.virusres.2024.199461.

References

Olijve L, Jennings L, Walls T . Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants. Clin Microbiol Rev. 2017; 31(1). PMC: 5740974. DOI: 10.1128/CMR.00047-17. View

Davis J, Fairley D, Christie S, Coyle P, Tubman R, Shields M . Human parechovirus infection in neonatal intensive care. Pediatr Infect Dis J. 2014; 34(2):121-4. DOI: 10.1097/INF.0000000000000510. View

Kadambari S, Harvala H, Simmonds P, Pollard A, Sadarangani M . Strategies to improve detection and management of human parechovirus infection in young infants. Lancet Infect Dis. 2018; 19(2):e51-e58. DOI: 10.1016/S1473-3099(18)30288-3. View

Harvala H, Robertson I, Chieochansin T, McWilliam Leitch E, Templeton K, Simmonds P . Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis. 2009; 199(12):1753-60. DOI: 10.1086/599094. View

Sridhar A, Karelehto E, Brouwer L, Pajkrt D, Wolthers K . Parechovirus A Pathogenesis and the Enigma of Genotype A-3. Viruses. 2019; 11(11). PMC: 6893760. DOI: 10.3390/v11111062. View

Harvala H, Calvert J, Van Nguyen D, Clasper L, Gadsby N, Molyneaux P . Comparison of diagnostic clinical samples and environmental sampling for enterovirus and parechovirus surveillance in Scotland, 2010 to 2012. Euro Surveill. 2014; 19(15). DOI: 10.2807/1560-7917.es2014.19.15.20772. View

Zell R, Delwart E, Gorbalenya A, Hovi T, King A, Knowles N . ICTV Virus Taxonomy Profile: Picornaviridae. J Gen Virol. 2017; 98(10):2421-2422. PMC: 5725991. DOI: 10.1099/jgv.0.000911. View

Kolehmainen P, Jaaskelainen A, Blomqvist S, Kallio-Kokko H, Nuolivirta K, Helminen M . Human parechovirus type 3 and 4 associated with severe infections in young children. Pediatr Infect Dis J. 2014; 33(11):1109-13. DOI: 10.1097/INF.0000000000000401. View

Harvala H, Wolthers K, Simmonds P . Parechoviruses in children: understanding a new infection. Curr Opin Infect Dis. 2010; 23(3):224-30. DOI: 10.1097/qco.0b013e32833890ca. View

10.

Harvala H, Robertson I, McWilliam Leitch E, Benschop K, Wolthers K, Templeton K . Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol. 2008; 46(10):3446-53. PMC: 2566073. DOI: 10.1128/JCM.01207-08. View

11.

Benschop K, Schinkel J, Minnaar R, Pajkrt D, Spanjerberg L, Kraakman H . Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis. 2005; 42(2):204-10. DOI: 10.1086/498905. View

12.

Kumar S, Stecher G, Tamura K . MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets. Mol Biol Evol. 2016; 33(7):1870-4. PMC: 8210823. DOI: 10.1093/molbev/msw054. View

13.

Fischer T, Midgley S, Dalgaard C, Nielsen A . Human parechovirus infection, Denmark. Emerg Infect Dis. 2014; 20(1):83-7. PMC: 3884717. DOI: 10.3201/eid2001.130569. View

14.

Edgar R . MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004; 32(5):1792-7. PMC: 390337. DOI: 10.1093/nar/gkh340. View

15.

Elling R, Bottcher S, du Bois F, Muller A, Prifert C, Weissbrich B . Epidemiology of Human Parechovirus Type 3 Upsurge in 2 Hospitals, Freiburg, Germany, 2018. Emerg Infect Dis. 2019; 25(7):1384-1388. PMC: 6590756. DOI: 10.3201/eid2507.190257. View

16.

Wang C, Ware R, Lambert S, Mhango L, Tozer S, Day R . Parechovirus A Infections in Healthy Australian Children During the First 2 Years of Life: A Community-based Longitudinal Birth Cohort Study. Clin Infect Dis. 2019; 71(1):116-127. PMC: 7108192. DOI: 10.1093/cid/ciz761. View

17.

Van der Sanden S, de Bruin E, Vennema H, Swanink C, Koopmans M, Van Der Avoort H . Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol. 2008; 46(9):2884-9. PMC: 2546772. DOI: 10.1128/JCM.00168-08. View

18.

Harvala H, McLeish N, Kondracka J, McIntyre C, McWilliam Leitch E, Templeton K . Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol. 2011; 83(5):889-96. DOI: 10.1002/jmv.22023. View

19.

Piralla A, Furione M, Rovida F, Marchi A, Stronati M, Gerna G . Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008-2010. J Med Virol. 2012; 84(4):686-90. PMC: 7166678. DOI: 10.1002/jmv.23197. View

20.

Nelson T, Vuillermin P, Hodge J, Druce J, Williams D, Jasrotia R . An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3. Sci Rep. 2017; 7:44423. PMC: 5349594. DOI: 10.1038/srep44423. View